About Circular Genomics
Circular Genomics is a company based in Albuquerque (United States) founded in 2021 by Nikolaos Mellios.. Circular Genomics has raised $28.99 million across 5 funding rounds from investors including The University of New Mexico, Alzheimer's Drug Discovery and Mountain Group Partners. The company has 1 employees as of July 01, 2024. Circular Genomics offers products and services including MindLight. Circular Genomics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Albuquerque, United States
- Employees 1 as on 01 Jul, 2024
- Founders Nikolaos Mellios
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Circular Genomics Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$28.99 M (USD)
in 5 rounds
-
Latest Funding Round
$15 M (USD), Series A
Dec 01, 2025
-
Investors
The University of New Mexico
& 5 more
-
Employee Count
1
as on Jul 01, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Circular Genomics
Circular Genomics offers a comprehensive portfolio of products and services, including MindLight. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Predicts patient response to antidepressants using circular RNA biomarkers.
Unlock access to complete
Unlock access to complete
Funding Insights of Circular Genomics
Circular Genomics has successfully raised a total of $28.99M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $15.0M
-
First Round
First Round
(18 Aug 2021)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Series A - Circular Genomics | Valuation | Mountain Group Partners | |
| Jul, 2025 | Amount | Grant - Circular Genomics | Valuation |
investors |
|
| Jan, 2024 | Amount | Series A - Circular Genomics | Valuation | Mountain Group Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Circular Genomics
Circular Genomics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include The University of New Mexico, Alzheimer's Drug Discovery and Mountain Group Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is directed toward life sciences and technology sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are focused on life sciences companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Circular Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Circular Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Circular Genomics Comparisons
Competitors of Circular Genomics
Circular Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Circular Genomics
Frequently Asked Questions about Circular Genomics
When was Circular Genomics founded?
Circular Genomics was founded in 2021.
Where is Circular Genomics located?
Circular Genomics is headquartered in Albuquerque, United States. It is registered at Albuquerque, New Mexico, United States.
Is Circular Genomics a funded company?
Circular Genomics is a funded company, having raised a total of $28.99M across 5 funding rounds to date. The company's 1st funding round was a Series A of $8.3M, raised on Aug 18, 2021.
How many employees does Circular Genomics have?
As of Jul 01, 2024, the latest employee count at Circular Genomics is 1.
What does Circular Genomics do?
Circular Genomics was founded in 2021 in Albuquerque, United States, within the biotechnology sector focused on genomics. RNA-based diagnostics and therapeutics are offered to address depression and related psychiatric conditions. A circular RNA-based genomic assay has been developed as a biomarker to predict therapeutic responses in individuals with neurological disorders. Operations center on advancing these tools for clinical applications.
Who are the top competitors of Circular Genomics?
Circular Genomics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Circular Genomics offer?
Circular Genomics offers MindLight.
Who are Circular Genomics's investors?
Circular Genomics has 6 investors. Key investors include The University of New Mexico, Alzheimer's Drug Discovery, Mountain Group Partners, Cottonwood Technology Fund, and Tramway Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.